Medifast announced that it has appointed Lauren Walker as executive vice president, Supply Chain Operations, effective Sept. 21, 2020. In her role, Walker will be responsible for overseeing Medifast’s global supply chain organization. As a key member of the company’s leadership team, she will report directly to Chief Executive Officer Dan Chard. “Over the last few…

Read More

(This article was originally released on August 3, 2020. It has been updated to reflect Q2 2020 financial reports released after that date.) Insights from Transformation Capital show that both large-cap and small-cap direct selling stocks continue to dramatically outperform the Dow Jones Industrial Average (DJIA). Large-Cap Stocks The four large-cap direct selling stocks continued to march higher…

Read More
Medifast Q2

Medifast, the company behind OPTAVIA®, reported revenue of $220.0 million for the second quarter ended June 30, 2020. Second quarter revenue increased 17.6% to $220.0 million from revenue of $187.1 million for the second quarter of 2019. OPTAVIA-branded products represented 83 percent of consumable units sold for the second quarter compared to 75 percent for the same period a year ago.…

Read More

Medifast recently hosted a new live broadcast event experience, OPTAVIA Together Live, replacing its traditional in-person convention, which was cancelled due to the global pandemic. The international event, streamed July 24–26, attracted more than 50,000 registrants from across the globe. The presentations generated more than 140,000 views on Facebook, as Coaches hosted watch parties and live events on…

Read More

Medifast, Inc. announced that it has appointed James (Jim) Maloney as chief financial officer, effective today. In his role, Maloney will be responsible for leading the finance function, including all aspects of financial planning and analysis, setting Medifast’s financial and capital allocation strategies and managing investor relations. He will serve as a member of the…

Read More

Nearly nine out of ten U.S. adults (88%) report experiencing stress during the pandemic, according to a survey conducted by Medifast. Additionally, 82 percent of those surveyed are concerned about at least one aspect of their physical or mental health, and one-fifth are struggling to make progress on their pre-pandemic health goals. Medifast, the company behind OPTAVIA®, surveyed…

Read More

OPTAVIA is the running-on-all-cylinders-engine propelling its parent company. As the Medifast/OPTAVIA corporate team gathered on the iconic platform at the New York Stock Exchange to ring the market’s opening bell on March 2, 2020, they were ready to celebrate more than just exceptional growth. The team dedicated the bell ringing to the more than 30,000…

Read More

Medifast (NYSE: MED), the company behind the health and wellness community OPTAVIA®, reported results for the first quarter ended March 31, 2020. First quarter revenue increased 7.6 percent to $178.5 million from revenue of $165.9 million for the first quarter of 2019. OPTAVIA-branded products represented 79 percent of consumable units sold for the first quarter compared to 73 percent for the same period…

Read More

Medifast, Inc. announced that Timothy G. Robinson, chief financial officer, will be stepping down from his position at the company on March 31, 2020. Medifast Chief Executive Officer Dan Chard and the Board of Directors have retained a leading international executive search firm to help the company identify and appoint a long-term successor to Robinson. Joseph Kelleman has…

Read More

Medifast (NYSE: MED) yesterday reported revenue increased 17 percent in the fourth quarter and 42.4 percent for the full year ended December 31, 2019. Fourth quarter revenue increased to $170.6 million from revenue of $145.8 million for the fourth quarter of 2018. OPTAVIA-branded products represented 79 percent of consumable units sold for the fourth quarter compared…

Read More